These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 2545860)

  • 21. Mechanisms of action of calcium-sensitizing drugs.
    Haikala H; Linden IB
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S10-9. PubMed ID: 8907127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization.
    Bowman P; Haikala H; Paul RJ
    J Pharmacol Exp Ther; 1999 Jan; 288(1):316-25. PubMed ID: 9862786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.
    Edes I; Kiss E; Kitada Y; Powers FM; Papp JG; Kranias EG; Solaro RJ
    Circ Res; 1995 Jul; 77(1):107-13. PubMed ID: 7788868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation.
    Haikala H; Nissinen E; Etemadzadeh E; Levijoki J; Lindén IB
    J Cardiovasc Pharmacol; 1995 May; 25(5):794-801. PubMed ID: 7630157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of MCI-154 on calcium sensitivity of contractile system and calcium release from sarcoplasmic reticulum in saponin-skinned rat myocardium.
    Huang Y; He ZH; Li YX
    Zhongguo Yao Li Xue Bao; 1997 May; 18(3):234-7. PubMed ID: 10072940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different effect of the Ca(2+) sensitizers EMD 57033 and CGP 48506 on cross-bridge cycling in human myocardium.
    Brixius K; Mehlhorn U; Bloch W; Schwinger RH
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1284-90. PubMed ID: 11082466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lusitropic effects of a Ca2+ sensitization with a new cardiotonic agent, MCI-154, on diseased human hearts.
    Mori M; Takeuchi M; Takaoka H; Yokoyama M
    Cardiovasc Res; 1995 Dec; 30(6):915-22. PubMed ID: 8746206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium sensitization in perfused beating guinea pig heart by a positive inotropic agent MCI-154.
    Abe Y; Ishisu R; Onishi K; Sekioka K; Narimatsu A; Nakano T
    J Pharmacol Exp Ther; 1996 Feb; 276(2):433-9. PubMed ID: 8632307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium-dependent activation of cardiac myofibrils. The mechanisms that modulate myofibrillar ATPase and tension and their significance for heart function.
    Rupp H
    Adv Myocardiol; 1982; 3():455-66. PubMed ID: 6302787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of inotropic action of xestoquinone, a novel cardiotonic agent isolated from a sea sponge.
    Kobayashi M; Nakamura H; Kobayashi J; Ohizumi Y
    J Pharmacol Exp Ther; 1991 Apr; 257(1):82-9. PubMed ID: 1850480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced positive feedback regulation between myosin crossbridge and cardiac troponin C in fast skeletal myofibrils.
    Morimoto S; Ohtsuki I
    J Biochem; 1996 Apr; 119(4):737-42. PubMed ID: 8743577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel cardiotonic agent SCH00013 acts as a Ca++ sensitizer with no chronotropic activity in mammalian cardiac muscle.
    Sugawara H; Endoh M
    J Pharmacol Exp Ther; 1998 Oct; 287(1):214-22. PubMed ID: 9765340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inotropic effects of MCI-154 on rat cardiac myocytes.
    Chen HZ; Cui XL; Zhao HC; Zhao LY; Lu JY; Wu BW
    Sheng Li Xue Bao; 2004 Jun; 56(3):301-5. PubMed ID: 15224141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the role of Ca++ binding proteins as possible targets for Ca++ sensitizing agents.
    Herzig JW; Quast U
    Z Kardiol; 1992; 81 Suppl 4():49-55. PubMed ID: 1290306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs.
    Abe Y; Kitada Y; Narimatsu A
    J Pharmacol Exp Ther; 1993 May; 265(2):819-25. PubMed ID: 8496827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac troponin I and tension generation of skinned fibres in the developing rat heart.
    Bartel S; Morano I; Hunger HD; Katus H; Pask HT; Karczewski P; Krause EG
    J Mol Cell Cardiol; 1994 Sep; 26(9):1123-31. PubMed ID: 7815456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a cardiotonic agent, MCI-154, on the contractile properties of skinned skeletal muscle fibers.
    Iwamoto H
    Eur J Pharmacol; 1998 Jan; 341(2-3):243-52. PubMed ID: 9543245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inotropic and lusitropic effects of MCI-154 (6-[4-(4- pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone) on human myocardium.
    Warren SE; Kihara Y; Pesaturo J; Gwathmey JK; Phillips P; Morgan JP
    J Mol Cell Cardiol; 1989 Oct; 21(10):1037-45. PubMed ID: 2555525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of MCI-154, a calcium sensitizer, on calcium sensitivity of myocardial contractile system in endotoxemic rats.
    Mei JM; Hu DY; Chen HS; Liu LM; Xiao N; Chen HH; Lu RQ
    Acta Pharmacol Sin; 2000 Sep; 21(9):830-4. PubMed ID: 11501166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mg-ATPase and Ca+ activated myosin AtPase activity in ventricular myofibrils from non-failing and diseased human hearts--effects of calcium sensitizing agents MCI-154, DPI 201-106, and caffeine.
    Okafor C; Liao R; Perreault-Micale C; Li X; Ito T; Stepanek A; Doye A; de Tombe P; Gwathmey JK
    Mol Cell Biochem; 2003 Mar; 245(1-2):77-89. PubMed ID: 12708747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.